Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 1 3Phase 1/2 2Phase NA 1Phase 3 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Virus Diseases 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hematologic Neoplasms 1Graft vs Host Disease 1

Interventions

Stem Cell Transplantation 2Interferon alpha-2 2thymoglobulin 1peginterferon alfa-2b 1peginterferon alfa-2a 1nilotinib 1fludarabine phosphate 1fludarabine 1Thiotepa 1Mycophenolic Acid 1Melphalan 1Imatinib Mesylate 1Gemtuzumab 1Dasatinib 1Cyclosporine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × thymoglobulin × Clear all
NCT02707393 2021-04-15

Allogeneic Stem Cell Transplantation for Children With CML

St. Anna Kinderkrebsforschung

Phase 2/3 Completed
13 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡